Extract of medicinal plant Artemisia annua interferes with replication of SARS-CoV-2 in vitro

Researchers in the United States have shown that extracts of an aromatic herb called Artemisia annua inhibit the replication of severe acute respiratory coronavirus (SARS-CoV-2) – the agent responsible for the current coronavirus disease 2019 (COVID-19) pandemic.

Artemisia annua L. extracts inhibit the in vitro replication of SARS-CoV-2 and two of its variants - ScienceDirect

SARS-CoV-2 omicron variants are susceptible in vitro to Artemisia annua hot water extracts - ScienceDirect

Frontiers Plant in vitro Culture Technologies; A Promise Into Factories of Secondary Metabolites Against COVID-19

Therapeutic Options for the SARS-CoV-2 Virus: Is There a Key in Herbal Medicine? - Nitin Sharma, Giriraj T. Kulkarni, Anant Narayan Bhatt, Saurabh Satija, Lubhan Singh, Anjana Sharma, Kamal Dua, Ritu Karwasra

Instant determination of the artemisinin from various Artemisia annua L. extracts by LC‐ESI‐MS/MS and their in‐silico modelling and in vitro antiviral activity studies against SARS‐CoV‐2 - Dogan - 2022 - Phytochemical Analysis

Antiviral, virucidal and antioxidant properties of Artemisia annua against SARS-CoV-2 - ScienceDirect

Frontiers Anti–SARS-CoV-2 Natural Products as Potentially Therapeutic Agents

Life, Free Full-Text

Pathogens, Free Full-Text

Frontiers Natural Plant Products: A Less Focused Aspect for the COVID-19 Viral Outbreak

Frontiers Anti–SARS-CoV-2 Natural Products as Potentially Therapeutic Agents